OrbiMed Israel GP II, L.P.

CIK 1682090
Transactions on file
17
Open-market buys
5
Win rate (buys)
100%
5 scored
Avg % since filing (buys)
+346.6%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
Buy588,235$10.00M+5.0%open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
Buy61,516$1.05M+5.0%open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C256,448$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C513,067$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C1,333,975$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C7,127,019$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
Buy300,249$5.10M+5.0%open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C564,187$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C769,601$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C2,000,962$0.00—open →
2026-09-302026-09-28ADRX
ADARx Pharmaceuticals, Inc.
Director10%
C10,690,530$0.00—open →
2026-04-092026-04-08ACET
Adicet Bio, Inc.
10%
Sale40,416$263.5K+47.1%open →
2026-04-092026-04-08ACET
Adicet Bio, Inc.
10%
Sale32,523$204.6K+52.5%open →
2026-04-092026-04-07ACET
Adicet Bio, Inc.
10%
Sale2,400$15.3K+50.3%open →
2026-04-092026-04-07ACET
Adicet Bio, Inc.
10%
Sale29,319$191.5K+46.9%open →
2025-10-102025-10-08ACET
Adicet Bio, Inc.
10%
Buy3,500,000$3.50M+859.0%open →
2025-10-102025-10-08ACET
Adicet Bio, Inc.
10%
Buy1,500,000$1.50M+859.0%open →